Home science-research Africa’s first-ever Phase 1 trial of a long-acting injectable for malaria prevention launches in Rwa Africa’s first-ever Phase 1 trial of a long-acting injectable for malaria prevention launches in Rwanda Medicines for Malaria Venture (MMV) and Rinda Ubuzima, a leading Rwandan health research organization, today announced the launch of a
Image via BusinessDay Nigeria. Supplied with the article; rights remain with the copyright holder . Africa's first-ever Phase 1 trial of a long-acting injectable for malaria prevention has launched in Rwanda, led by Medicines for Malaria Venture and Rinda Ubuzima.
Medicines for Malaria Venture (MMV) and Rinda Ubuzima, a leading Rwandan health research organization, today announced the launch of a
Mukoko keeps a record of every source — how many of its articles we hold, when we last read its feed, how long it has been delivering, and how we established its country.
Articles held Feed last read Delivering since Country About this article Length
Published November 2, 2026
Byline Ifeoma Okeke-Korieocha 
